CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Spinal Muscular Atrophy Type I
Interventions
DRUG

Valproic Acid and Levocarnitine

Drug: Valproic Acid and Levocarnitine; syrup; dosage is by weight

Trial Locations (8)

21287

Johns Hopkins University, Baltimore

27710

Duke University Medical Center, Durham

43210

Ohio State University Medical Center, Dept. of Neurology, Columbus

48201

Children's Hospital of Michigan, Detroit

50924

Klinikum der Universität zu Köln, Cologne

84132

University of Utah/Primary Children's Medical Center, Salt Lake City

53792-9988

University of Wisconsin Children's Hospital, Madison

H3T 1C5

Hospital Sainte-Justine, Montreal

Sponsors
All Listed Sponsors
collaborator

Families of Spinal Muscular Atrophy

OTHER

collaborator

Leadiant Biosciences, Inc.

INDUSTRY

lead

University of Utah

OTHER

NCT00661453 - CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I | Biotech Hunter | Biotech Hunter